Glenmark Pharmaceuticals Inc., Usa: Abiraterone Acetate Tablets Usp 500 Mg, 60-count Bottles
Recall Summary Glenmark Pharmaceuticals is recalling Abiraterone Acetate Tablets USP 500 mg in 60-count bottles nationwide due to a labeling issue. This is a prescription medication used to treat certain types of cancer. The recall affects bottles distributed across all U.S. states and Washington, D.C.
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Product
- Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60
- Reason
- Labeling: Not Elsewhere Classified
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-10-09
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/700bb75f-3310-4bd5-9cd9-981f13b86aec